Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Approved Drug Products containing Naloxone Hydrochloride listed with Health Canada. Original Data : Health Canada Website

Client Email

Product

Naloxone Hydrochloride
Noroxymorphone API
Buprenorphine Hydrochloride
Canada

PharmaCompass Sponsored Ads

Contact Supplier

Temad Naloxone Hydrochloride

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

Veranova: A CDMO that manages complexity with confidence.

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

Naloxone Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

27 API Suppliers, 13 USDMF, 11 CEP/COS, 1 JDMF, 2 EU WC, 2 KDMF, 18 NDC API, 17 Listed Suppliers, $ API Reference Price

27 API Suppliers
13 USDMF
11 CEP/COS
1 JDMF
2 EU WC
2 KDMF
18 NDC API
17 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

55 Drugs in Development

55 Drugs in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

API Reference Price
API Exports
API Imports
FDF Exports
FDF Imports

INTERMEDIATES

5 API Suppliers

5 API Suppliers

FINISHED DOSAGE FORMULATIONS

310 FDF Dossiers, 161 FDA Orange Book, 83 Europe, 13 Canada, 16 Australia, 7 South Africa, 30 Listed Dossiers

310 FDF Dossiers
161 FDA Orange Book
83 Europe
13 Canada
16 Australia
7 South Africa
30 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FILM;BUCCAL - EQ 2.1MG BASE;EQ 0.3MG BASE, FILM;BUCCAL - EQ 4.2MG BASE;EQ 0.7MG BASE, FILM;BUCCAL - EQ 6.3MG BASE;EQ 1MG BASE, SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS - 0.4MG/0.4ML (0.4MG/0.4ML), TABLET;SUBLINGUAL - EQ 2MG BASE;EQ 0.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;SUBLINGUAL - EQ 8MG BASE;EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS - 2MG/0.4ML (2MG/0.4ML), FILM;BUCCAL, SUBLINGUAL - EQ 12MG BASE;EQ 3MG BASE, FILM;BUCCAL, SUBLINGUAL - EQ 2MG BASE;EQ 0.5MG BASE, FILM;BUCCAL, SUBLINGUAL - EQ 4MG BASE;EQ 1MG BASE, FILM;BUCCAL, SUBLINGUAL - EQ 8MG BASE;EQ 2MG BASE

FILM;BUCCAL - EQ 2.1MG BASE;EQ 0.3MG BASE
FILM;BUCCAL - EQ 4.2MG BASE;EQ 0.7MG BASE
FILM;BUCCAL - EQ 6.3MG BASE;EQ 1MG BASE
SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS - 0.4MG/0.4ML (0.4MG/0.4ML)
TABLET;SUBLINGUAL - EQ 2MG BASE;EQ 0.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;SUBLINGUAL - EQ 8MG BASE;EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS - 2MG/0.4ML (2MG/0.4ML)
FILM;BUCCAL, SUBLINGUAL - EQ 12MG BASE;EQ 3MG BASE
FILM;BUCCAL, SUBLINGUAL - EQ 2MG BASE;EQ 0.5MG BASE
FILM;BUCCAL, SUBLINGUAL - EQ 4MG BASE;EQ 1MG BASE
FILM;BUCCAL, SUBLINGUAL - EQ 8MG BASE;EQ 2MG BASE

RELATED EXCIPIENT COMPANIES

1 Minakem, 4 Rochem International Inc, 17 SPI Pharma, 2 Seqens, 1 DKSH, 2 Jai Radhe Sales, 1 Pharm-RX Chemical, 3 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 14 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 10 Actylis, 1 Alcedo Pharmachem, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 16 BASF, 1 Bioplus Life Sciences, 10 Corel Pharma Chem, 6 DFE Pharma, 2 Finar, 7 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 37 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 7 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 23 Roquette, 7 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

84 Fillers, Diluents & Binders, 45 Coating Systems & Additives, 40 Direct Compression, 25 Taste Masking, 25 Controlled & Modified Release, 24 Thickeners and Stabilizers, 23 Granulation, 22 Disintegrants & Superdisintegrants, 20 Lubricants & Glidants, 19 Co-Processed Excipients, 18 Chewable & Orodispersible Aids, 12 Parenteral, 8 Solubilizers, 8 Topical, 7 Film Formers & Plasticizers, 6 API Stability Enhancers, 5 Empty Capsules, 4 Emulsifying Agents, 4 Vegetarian Capsules, 3 Rheology Modifiers, 2 Coloring Agents, 1 Surfactant & Foaming Agents

84 Fillers, Diluents & Binders
45 Coating Systems & Additives
40 Direct Compression
25 Taste Masking
25 Controlled & Modified Release
24 Thickeners and Stabilizers
23 Granulation
22 Disintegrants & Superdisintegrants
20 Lubricants & Glidants
19 Co-Processed Excipients
18 Chewable & Orodispersible Aids
12 Parenteral
8 Solubilizers
8 Topical
7 Film Formers & Plasticizers
6 API Stability Enhancers
5 Empty Capsules
4 Emulsifying Agents
4 Vegetarian Capsules
3 Rheology Modifiers
2 Coloring Agents
1 Surfactant & Foaming Agents

DIGITAL CONTENT

3 DATA COMPILATION #PharmaFlow, 234 NEWS #PharmaBuzz

3 DATA COMPILATION #PharmaFlow
234 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 76 Finished Drug Prices

2 US Medicaid Prescriptions
76 Finished Drug Prices

MARKET PLACE

15 APIs, 10 FDF Dossiers

15 APIs
10 FDF Dossiers

PATENTS & EXCLUSIVITIES

183 US Patents, 3 US Exclusivities

183 US Patents
3 US Exclusivities

REF. STANDARDS & IMPURITIES

3 EDQM, 1 USP, 5 Others

3 EDQM
1 USP
5 Others

$ API Ref.Price (USD/KG) : 11,195 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

13 All

01 1EMERGENT OPERATIONS IRELAND LIMITED

02 2HIKMA CANADA LIMITED

03 2OMEGA LABORATORIES LIMITED

04 4PURDUE PHARMA

05 3SANDOZ CANADA INCORPORATED

06 1TEVA CANADA LIMITED

filter Active Ingredients Reset all filters

13 All

01 10NALOXONE HYDROCHLORIDE

02 3NALOXONE HYDROCHLORIDE (NALOXONE HYDROCHLORIDE DIHYDRATE)

filter Dosage Form Reset all filters

13 All

01 2LIQUID

02 5SOLUTION

03 2SPRAY, METERED DOSE

04 4TABLET (EXTENDED-RELEASE)

filter Brand Name Reset all filters

13 All

01 1INJECTABLE NALOXONE HYDROCHLORIDE

02 1NALOXONE HCL INJECTION - 0.4MG/ML USP

03 1NALOXONE HCL INJECTION - 1MG/ML USP

04 1NALOXONE HYDROCHLORIDE INJECTION

05 1NALOXONE HYDROCHLORIDE INJECTION USP

06 1NALOXONE INJECTABLE

07 1NARCAN NASAL SPRAY

08 1S.O.S. NALOXONE HYDROCHLORIDE INJECTION

09 4TARGIN

10 1TEVA-NALOXONE NASAL SPRAY

Veranova Naloxone hydrochloride

FDF Dossiers
FDA Orange Book
Europe
Canada
Australia
South Africa
Listed Dossiers

List of Suppliers

Product Main Page

01

EMERGENT OPERATIONS IRELAND LIMITED

Boulder Peptide 2024

Not Confirmed

EMERGENT OPERATIONS IRELAND LIMITED

Boulder Peptide 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Ethical

Registration Country : Canada

NALOXONE HYDROCHLORIDE

Brand Name : NARCAN NASAL SPRAY

Dosage Form : SPRAY, METERED DOSE

Dosage Strength : 4MG/0.1ML

Packaging :

Approval Date :

Application Number : 2458187

Regulatory Info : Ethical

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

02

HIKMA CANADA LIMITED

Boulder Peptide 2024

Not Confirmed

HIKMA CANADA LIMITED

Boulder Peptide 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Ethical

Registration Country : Canada

NALOXONE HYDROCHLORIDE

Brand Name : NALOXONE INJECTABLE

Dosage Form : SOLUTION

Dosage Strength : 0.4MG/ML

Packaging :

Approval Date :

Application Number : 2458578

Regulatory Info : Ethical

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

HIKMA CANADA LIMITED

Boulder Peptide 2024

Not Confirmed

HIKMA CANADA LIMITED

Boulder Peptide 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

NALOXONE HYDROCHLORIDE (NALOXONE HYDROCHLORIDE DIHYDRATE)

Brand Name : NALOXONE HYDROCHLORIDE INJECTION USP

Dosage Form : SOLUTION

Dosage Strength : 0.4MG/ML

Packaging : 10X1ML

Approval Date :

Application Number : 2382482

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

OMEGA LABORATORIES LIMITED

Boulder Peptide 2024

Not Confirmed

OMEGA LABORATORIES LIMITED

Boulder Peptide 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

NALOXONE HYDROCHLORIDE (NALOXONE HYDROCHLORIDE DIHYDRATE)

Brand Name : NALOXONE HYDROCHLORIDE INJECTION

Dosage Form : SOLUTION

Dosage Strength : 1MG/ML

Packaging : 10X2ML

Approval Date :

Application Number : 2393042

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

PURDUE PHARMA

Boulder Peptide 2024

Not Confirmed

PURDUE PHARMA

Boulder Peptide 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

NALOXONE HYDROCHLORIDE

Brand Name : TARGIN

Dosage Form : TABLET (EXTENDED-RELEASE)

Dosage Strength : 2.5MG

Packaging : 10/14/20/28/30/50/56/60/98/100/250

Approval Date :

Application Number : 2387425

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

PURDUE PHARMA

Boulder Peptide 2024

Not Confirmed

PURDUE PHARMA

Boulder Peptide 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

NALOXONE HYDROCHLORIDE

Brand Name : TARGIN

Dosage Form : TABLET (EXTENDED-RELEASE)

Dosage Strength : 5MG

Packaging : 50/60/100/250/10/14/20/28/30/50/56/60/98

Approval Date :

Application Number : 2339609

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

PURDUE PHARMA

Boulder Peptide 2024

Not Confirmed

PURDUE PHARMA

Boulder Peptide 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

NALOXONE HYDROCHLORIDE

Brand Name : TARGIN

Dosage Form : TABLET (EXTENDED-RELEASE)

Dosage Strength : 10MG

Packaging : 50/60/100/250/10/14/20/28/30/50/56/60/98

Approval Date :

Application Number : 2339617

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

PURDUE PHARMA

Boulder Peptide 2024

Not Confirmed

PURDUE PHARMA

Boulder Peptide 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

NALOXONE HYDROCHLORIDE

Brand Name : TARGIN

Dosage Form : TABLET (EXTENDED-RELEASE)

Dosage Strength : 20MG

Packaging : 50/60/100/250/10/14/20/28/30/50/56/60/98

Approval Date :

Application Number : 2339625

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

SANDOZ CANADA INCORPORATED

Boulder Peptide 2024

Not Confirmed

SANDOZ CANADA INCORPORATED

Boulder Peptide 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

NALOXONE HYDROCHLORIDE

Brand Name : NALOXONE HCL INJECTION - 1MG/ML USP

Dosage Form : LIQUID

Dosage Strength : 1MG/ML

Packaging : 2ML

Approval Date :

Application Number : 2148714

Regulatory Info : Prescription

Registration Country : Canada

Product Web Link

Digital Content

10

SANDOZ CANADA INCORPORATED

Boulder Peptide 2024

Not Confirmed

SANDOZ CANADA INCORPORATED

Boulder Peptide 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

NALOXONE HYDROCHLORIDE

Brand Name : NALOXONE HCL INJECTION - 0.4MG/ML USP

Dosage Form : LIQUID

Dosage Strength : 0.4MG/ML

Packaging : 1/10ML

Approval Date :

Application Number : 2148706

Regulatory Info : Prescription

Registration Country : Canada

Product Web Link

Digital Content

1
2

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?